| Basics |
| Company: |
Kura Oncology, Inc. |
| IPO Date: |
September 16, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$677.25M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.40 | 2.81%
|
| Avg Daily Range (30 D): |
$0.21 | 2.58%
|
| Avg Daily Range (90 D): |
$0.27 | 2.21%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.45M |
| Avg Daily Volume (30 D): |
1.3M |
| Avg Daily Volume (90 D): |
1.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
91 |
| Avg Trade Size (Sh.) (30 D): |
95 |
| Avg Trade Size (Sh.) (90 D): |
98 |
| Institutional Trades |
| Total Inst.Trades: |
2,661 |
| Avg Inst. Trade: |
$1.89M |
| Avg Inst. Trade (30 D): |
$2.88M |
| Avg Inst. Trade (90 D): |
$1.88M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.07M |
| Avg Closing Trade (30 D): |
$1.89M |
| Avg Closing Trade (90 D): |
$1.9M |
| Avg Closing Volume: |
124.12K |
|
|
|
|
| News |
Sep 30, 2024 @ 10:30 PM
Kura Oncology Announces Publication of Ziftomenib ...
Source: Kura Oncology, Inc.
|
Jun 24, 2024 @ 11:30 AM
Kura Oncology Reports Preclinical Data Supporting ...
Source: Kura Oncology, Inc.
|
Jun 7, 2024 @ 11:30 AM
Kura Oncology Reports Inducement Grants Under Nasd...
Source: Kura Oncology, Inc.
|
May 29, 2024 @ 11:30 AM
Kura Oncology to Participate in Jefferies Global H...
Source: Kura Oncology, Inc.
|
May 14, 2024 @ 11:30 AM
Kura Oncology Completes Enrollment in Registration...
Source: Kura Oncology, Inc.
|
| Financials |
| |
TTM |
Q2 2024 |
Q1 2024 |
|
Basic EPS
|
$-.63
|
$-.59
|
$-.59
|
|
Diluted EPS
|
$-.63
|
$-.59
|
$-.59
|
|
Revenue
|
$
|
$
|
$
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -54.4M
|
$ -50.84M
|
$ -49.53M
|
|
Operating Income / Loss
|
$
|
$
|
$
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 4.3M
|
$ 3.68M
|
$ 4.19M
|
|
PE Ratio
|
|
|
|
|
